Product analysis
Once-Daily Health Booster brings together nutrients with antioxidant roles and limited support for artery flexibility. Unidentified blend components make the full formula harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality32
Some ingredient sources are named, but unclear vitamin K and saffron forms limit a close comparison. The unidentified blend and inconsistent quantity declarations also leave the full preparation uncertain.
Ingredient Transparency68
Amounts are declared, but differing declarations cannot be combined into a dependable total for every ingredient. Some forms and blend component proportions are also unclear.
Value For Money47
Vitamin K and chlorophyllin offer reasonable value at the serving cost. Vitamin E value remains uncertain, so those comparisons do not establish the value of the whole blend.
Customer Satisfaction77
Customer ratings are positive across a sizeable body of feedback. The reviews give useful context about satisfaction without demonstrating the proposed health effects.
Product Focus40
The formula combines antioxidant nutrition with several different proposed uses. The heart-related findings concern a particular vitamin K preparation in selected postmenopausal women, while the toxin-related findings concern a specific food exposure.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.72
- Also available
Once-Daily Health Booster$21.60- Customer rating
- 4.5 · 1,031 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin E (D-Alpha-Tocopherol) | 30.2 mg | |
Vitamin K | 3735 mcg | |
MacuGuard Proprietary Blend | 173 mg | |
Chlorophyllin (Sodium Magnesium Chlorophyllin) | 100 mg | |
Mixed Tocotrienols | 55 mg | |
Saffron extract | 20 mg | |
Lycopene Proprietary Blend (Lyc-O-Mato natural Tomato extract, micronized Lycopene) | 10 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability80
Chlorophyllin Compound Form
Source and Purity Clarity
Dose, Safety & Label Transparency63
Chlorophyllin Potency
Elemental Mineral Transparency
Value50
Price per 100mg Active Chlorophyllin
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
MK-7 Isomer Disclosure
Dose, Safety & Label Transparency82
Vitamin K2 (MK-7) Dosage Efficacy
Form and Subtype Transparency
Value50
Price per Effective MK-7 Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
- Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
- The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
- Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
- Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
- Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
- Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.
- Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer
- Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
- Effect of vitamin E on cardiometabolic factors in paediatric metabolic dysfunction-associated steatotic liver disease: a systematic review with meta-analysis.
- Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
- Vitamin E administration reduces liver enzyme levels in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): evidence from a systematic review and meta-analysis.
- Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
- Low dietary vitamin E intake is associated with high risk of incident dementia among older adults: The Shanghai Aging Study.
- Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study.